Skip to main content
TipRanks
Go Ultimate75% OFF

Magnera (MAGN) AI Stock Analysis

0 Followers
CH:MAGN

Magnera

(BX Swiss:MAGN)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Strong revenue growth and cash generationRapid sales growth combined with positive and expanding free cash flow indicates improving cash economics across the business. This supports internal funding of investment and debt reduction, while giving Magnera greater resilience as it works to convert growth into durable profitability.
Negative Factors
Persistent losses and thin marginsMagnera’s rapid revenue expansion has not yet translated into positive bottom-line earnings, while thin gross and EBITDA margins leave limited protection against cost pressure. Sustained losses constrain retained capital and make durable earnings conversion a central execution challenge.

Magnera Business Overview & Revenue Model

Company Description

Magnera Corporation manufactures and sells non-woven and related products worldwide. It sells its products primarily into consumer-oriented end markets, such as healthcare, and personal care. The company offers personal care and consumer solution pro...

Magnera Earnings Call Summary

Earnings Call Date:Nov 19, 2026(Q4-2026)|Next Earnings Date:Feb 11, 2027
Earnings Call SentimentPositive

The call was broadly positive, supported by year-over-year earnings growth, strong free cash flow, debt reduction, synergy realization, operational improvements, product innovation and fiscal 2027 EBITDA growth guidance of approximately 6%. However, management also highlighted softer volumes, European and Chinese macroeconomic headwinds, inflation and energy costs, inventory volatility, an impairment charge and leverage that remains above the 3x target. The achievements and outlook significantly outweighed the stated challenges.

Positive Updates

Merger Synergies and Project CORE Execution
Magnera delivered its synergy savings commitment to date, with the remaining value expected to be captured in fiscal 2027. The company executed Project CORE portfolio and footprint actions in Argentina, the U.K. and France, and reported that the initiative has evolved into its business excellence operating platform.

Negative Updates

Macroeconomic Headwinds in Europe and China
Management expects Europe and China to remain exposed to the economic implications of the Iran war, with another year of headwinds pressuring volume growth and supporting a flattish Rest of World outlook.

Company Guidance

For fiscal 2027, Magnera is guiding to an expected EBITDA earnings improvement of 6%, with comparable EBITDA at the midpoint of $400 million expected to grow approximately 6% year-over-year on a constant currency basis; volume assumptions are essentially low single-digit growth in the Americas, slightly low single-digit negative or flattish in Europe, with the midpoint being flat from a volume standpoint, the higher end of the EBITDA range being plus 2% on volume and the lower end being 2% less. Free cash flow is expected to range from $110 million to $130 million and be back half weighted, with approximately $85 million of capital investments; at the midpoint, about $120 million of free cash flow is intended for debt reduction, with leverage at roughly 3.6x as the company marches towards its 3x target, alongside $125 million of cash interest, $50 million of tax integration, $20 million of additional Project CORE items, and cash taxes of 10% to 11% as a percentage of EBITDA. Rollover benefits are roughly $20 million from 2026 actions versus roughly $45 million of benefit in 2026, Europe is roughly 70% hedged for 2027 energy, and extra shipping days are expected to provide around $5 million or $6 million of benefit.

Magnera Risk Analysis

Magnera disclosed 32 risk factors in its most recent earnings report. Magnera reported the most risks in the "Macro & Political" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Macro & Political - Risks related to catastrophic events or geopolitical conditions that may disrupt the company’s business

Latest Risks Added

0 New Risks

Magnera Peers Comparison

Overall Rating

UnderperformOutperform
Sector (62)

Financial Indicators

CH:MAGN against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
REYNREYN75Outperform$5.17B15.7914.15%3.78%2.45%6.45%
PGPG72Outperform$389.04B25.0529.55%2.55%3.52%-3.74%
KMBKMB69Neutral$64.59B10.71162.62%4.79%-8.38%67.47%
CLXCLX64Neutral$12.71B18.84-1920.57%4.76%6.28%-13.15%
Sector *62Neutral$20.33B14.63-3.31%3.23%1.93%-12.26%
EPCEPC51Neutral$1.27B-25.65-3.53%2.11%-10.21%-310.40%

* Consumer Defensive Sector Average

Performance Comparison

-20%0%20%40%60%CLXKMBPGEPCREYNDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
CH:MAGN and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
CLXClorox Company104.734.184.16%
KMBKimberly Clark106.386.466.47%
PGProcter & Gamble Company169.3726.5318.58%
EPCEdgewell Personal Care Co28.4711.5067.76%
REYNReynolds Consumer Products Inc24.320.933.99%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.